Page 18 - FLIPBOOK

RT in high-risk M0 prostate cancer

• Prognosis of Randomised by 01-May-2014
N=5,573
newly-diagnosed

high-risk M0 Allocated to control arm Allocated to research arms

N=1858 N=3,715
disease

• Cohort selection: Metastatic Non-metastatic

N=1090 N=788

Diagnosed more than 6m Diagnosed within 6m
pre-randomisation pre-randomisation
N=67 N=721